2017 annual financial data
China SXT Pharmaceuticals 2017 Operating margin
Direct answer
Operating margin was 32.82%.
Operating income was 1,602,182 USD and net income was 1,185,146 USD.
Operating cash flow was 293,042 USD.
Get free China SXT Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,881,523 USD
- Operating income
- 1,602,182 USD
- Net income
- 1,185,146 USD
- Operating cash flow
- 293,042 USD